메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

바이탈 머티리얼즈, 양자 플럭스 광자 계수 CT(PCCT) 완전 수직 통합 기술 공개

[ 메디채널 김갑성 기자 ] 베이징 2025년 8월 21일 -- 8월 15일부터 17일까지 베이징에서 제31회 중국 국제 의료장비 전시회 및 과학 콘퍼런스(China-Hospeq 2025)가 개최됐다. 바이탈 머티리얼즈(Vital Materials)는 중국이 자체적으로 개발한 광자 계수 CT(PCCT) 스캐너 VITA Genesis를 공식 출시하며, 글로벌 의료 영상 기술이 '양자 플럭스(Quantum Flux)' 감지 시대에 진입했음을 알렸다. 이번 출시는 중국의 정밀 진단 및 치료 혁신에 힘을 실었다. PCCT의 핵심 기술인 광자 계수 검출기(PCD)는 기존 에너지 통합 검출기(EID)와 상당한 차이가 있다. 기존 CT 스캐너는 X선 광자를 먼저 가시광선으로 변환한 뒤, 다시 전기 신호로 바꾸는 과정을 거친다. 반면 PCCT 검출기는 반도체 소재를 활용해 X선 광자가 전자를 활성화해 에너지에 비례하는 전자-정공 쌍을 형성한다. 이렇게 발생한 전하 운반체는 전기장에 의해 분리돼 전기 펄스를 만들어낸다. ASIC(애플리케이션별 집적 회로)는 이 펄스를 에너지 구간별로 분류해 정밀한 광자 계수와 에너지 분해능을 제공한다. 이러한
- 김갑성 기자
- 2025-08-21 08:52
Telix 2025 Half-Year Results: Strong commercial performance…

MELBOURNE, Australia and INDIANAPOLIS, Aug. 21, 2025 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the half-year ended 30 June 2025. All figures are in USD unless stated otherwise. H1 2025 key results[1] Group performance[2]: Reflects strategic investment for long-term value creation Revenue of $390.4 million, up by 63%[3] and on track to meet full year guidance[4]. Group gross profit margin of 53% reflects product mix change to include third-party RLS sales. Illuccix® m
- 김갑성 기자
- 2025-08-21 08:23
Angelalign Technology Denies Patent Infringement and Vo…

SAN CLEMENTE, Calif., Aug. 21, 2025 -- Angelalign Technology Inc. (6699.HK) ("Angel") categorically denies accusations of patent infringement by Align Technology Inc. (ALGN) and promises a vigorous defense. "Angel has a rich heritage of clinically driven innovation during its 20-plus year history. Accusations by our competitor of patent violations are frivolous and entirely without merit," said Angel's Chief Commercial Officer and SVP, Rich Hirschland. "Angel has invested heavily in patent compliance since our founding. We are confide
- 김갑성 기자
- 2025-08-21 05:04
Sisram Medical Reports First-Half 2025 Results: Injectables Su…

HONG KONG, Aug. 20, 2025 -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; referred to collectively with its subsidiaries as the "Group"), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business building blocks and consumer-focused approaches including Energy-Based Devices (EBD), and Injectables, alongside other complementary offerings, today announced its unaudited consolidated interim results for the six months ended June 30, 2025 (the "Reporting Period"). FINANCIAL HIGHLIGHTS Revenue was
- 김갑성 기자
- 2025-08-20 22:14
Zylox-Tonbridge Announces 2025 Interim Results: Strong Re…

HANGZHOU, China, Aug. 20, 2025 -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, hereinafter referred to as "Zylox-Tonbridge" or the "Company") today announced its interim results for the six months ended June 30, 2025. The Company achieved robust revenue growth of 31.7% year-over-year (YoY) to RMB 482 million, while net profit surged by 76.0% to exceed RMB 121 million, representing a net profit margin of 25.1%. In the first half of 2025, Zylox-Tonbridge maintained solid performance in its core neurovascular and peripheral vascular intervention businesses
- 김갑성 기자
- 2025-08-20 21:41
IBM and NASA Release Groundbreaking Open-Source AI Mode…

[ 메디채널 김갑성 기자 ] The first heliophysics AI foundation model trained on high resolution solar observation data offers insights into the Sun's dynamic surface, helping plan for solar weather that can disrupt technology on Earth and in space Openly available on Hugging Face, the model was built to speed up scientific discovery and democratize AI for the global research and technology community Researchers also release the largest known curated heliophysics dataset to advance data driven space weather research YORKTOWN HEIGHTS, N.Y., Aug. 20, 2025 -- IBM (NYSE: IBM) and NAS
- 김갑성 기자
- 2025-08-20 21:00
Cell therapy is promising in treating psychiatric disorders, s…

SHANGHAI, Aug. 20, 2025 -- On August 11, 2025, the research team led by Professor Yuejun Chen, founder of UniXell Biotech, published an article titled "Human stem cell-derived A10 dopaminergic neurons specifically integrate into mouse circuits and improve depression-like behaviors" in Cell Stem Cell, featured as a cover story. This study marks the first establishment of a technique to efficiently and directionally differentiate human pluripotent stem cells (hPSCs) into A10 subtype dopamine neurons. This breakthrough lays a critical scientific foundation for cell therapy of psychiatr
- 김갑성 기자
- 2025-08-20 20:49
Ping An Good Doctor (1833.HK) Reports Solid Interim Results with…

HONG KONG, Aug. 20, 2025 -- Ping An Healthcare and Technology Company Limited (the "Company"; Stock Code: 1833.HK) announced its interim results for the six months ended June 30, 2025, on August 19, 2025. Following its return to profitability in 2024, the Company maintained high growth and improved profitability during the reporting period, with core business development and continuous advancement in its medical AI capabilities. In terms of financial performance, the Company recorded revenue of RMB2.5 billion during the period, representing a year-on-year increase of
- 김갑성 기자
- 2025-08-20 19:19
First Patient Dosed in Pivotal Phase III Trial of Cadonilimab (PD-1…

HONG KONG, Aug. 20, 2025 -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the enrollment and dosing of the first patient in the pivotal Phase III clinical trial (AK104-310/COMPASSION-33) evaluating cadonilimab, a first-in-class PD-1/CTLA-4 bispecific antibody developed by Akeso, in combination with chemotherapy for the perioperative treatment of resectable gastric/gastroesophageal junction (G/GEJ) adenocarcinoma. The COMPASSION-33 study represents the third Phase III trial for cadonilimab in gastric cancer. The study aims to improve the radical resectio
- 김갑성 기자
- 2025-08-20 16:11
DKSH Healthcare Establishes Industry Benchmark in Carbon…

DKSH Business Unit Healthcare has reached a significant milestone in building a more sustainable healthcare supply chain by successfully tracking carbon emissions across its value chain through a collaboration with UOB FinLab's GreenTech Accelerator and Smart Tradzt in Thailand. This achievement also marks the implementation of a reusable cold-chain packaging solution. The initiative underscores DKSH Healthcare's ongoing commitment to environmental responsibility and its proactive approach to advancing sustainable business practices. BANGKOK, Aug. 20, 2025 -- DKSH Business Unit
- 김갑성 기자
- 2025-08-20 12:00

이전

61 62 63 64 65 66 67 68 69 70

많이 본 기사

최근기사

2025-10-22_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 22일 19시 40분